Pare and Machipisa

American Heart Association (AHA) Scientific Sessions 2021 included presentations by several PHRI researchers.

Guillaume Pare, PHRI Senior Scientist and Director, CRLB-GMEL, gave the on-demand presentation, Discovery of Novel Causal Mediators Using Biobanks and Multi-omics Technologies. His talk was part of the session, The Era of Multi-Omics for Cardiovascular Disease.

Shamir Mehta, PHRI Senior Scientist, gave on-demand presentations on: Debates in the Management of NSTEACs; he argued Pro: All high-risk patients with NSTEACS should undergo immediate/early angiography versus Con – Thomas Engstrom, Denmark.

In STEMI and Hot Topics, Shamir Mehta presented on STEMI and MVD: COMPLETE revascularization timing, imaging, and more.

Harriette Van Spall

PHRI Scientist Harriette Van Spall participated in the session, A Roadmap to Closing the Gender Gap in Cardiovascular Clinical Trial Leadership on Nov. 13. She presented on Diversity Gap: Culprits, Consequences, and a Roadmap for Change.

Working with Gui Pare in the CRLB-GMEL, PhD student Tafadzwa Machipisa participated in the session, New Data in Genomic Science with her presentation, “Analysis Suggests Enrichment of Heart Valve Tissue Expression in African Rheumatic Heart Disease Patients From the RHDGen GWAS Study Cohort. It was based on the 2021 JAMA Cardiology publication she co-authored with Gui Pare and University of Cape Town scientists.

Here are just a few of the #AHA21 Tweets coming out of the event:

Back To Top